54 related articles for article (PubMed ID: 19792965)
1. Impact of PET/CT Imaging with FDG in Locally Advanced Cervical Carcinoma-A Literature Review.
Molnar O; Straciuc OM; Mihuțiu S; Lazăr L
Curr Oncol; 2024 Apr; 31(5):2508-2526. PubMed ID: 38785469
[TBL] [Abstract][Full Text] [Related]
2. [Validity of CT examination before comprehensive therapy of carcinoma of the uterine cervix].
Kudela M; Lubuský D; Jabůrek L; Turková M
Ceska Gynekol; 1995 Feb; 60(1):42-4. PubMed ID: 7719593
[No Abstract] [Full Text] [Related]
3. Cervical cancer in the pregnant population.
Nguyen T; Nougaret S; Castillo P; Paspulati R; Bhosale P
Abdom Radiol (NY); 2023 May; 48(5):1679-1693. PubMed ID: 37071123
[TBL] [Abstract][Full Text] [Related]
4. A novel 2-deoxy-2-fluorodeoxyglucose (
Liu S; Feng Z; Zhang J; Ge H; Wu X; Song S
Quant Imaging Med Surg; 2021 Jan; 11(1):240-248. PubMed ID: 33392025
[TBL] [Abstract][Full Text] [Related]
5. Detection of distant metastatic disease by positron emission tomography with
Lin A; Ma S; Dehdashti F; Markovina S; Schwarz J; Siegel B; Powell M; Grigsby P
Int J Gynecol Cancer; 2019 Mar; 29(3):487-491. PubMed ID: 30739082
[TBL] [Abstract][Full Text] [Related]
6. [18F]-2-Fluoro-2-Deoxy-D-glucose-PET Assessment of Cervical Cancer.
Viswanathan C; Faria S; Devine C; Patnana M; Sagebiel T; Iyer RB; Bhosale PR
PET Clin; 2018 Apr; 13(2):165-177. PubMed ID: 29482748
[TBL] [Abstract][Full Text] [Related]
7. Survival outcomes in patients with cervical cancer after inclusion of PET/CT in staging procedures.
Hansen HV; Loft A; Berthelsen AK; Christensen IJ; Høgdall C; Engelholm SA
Eur J Nucl Med Mol Imaging; 2015 Nov; 42(12):1833-9. PubMed ID: 26194714
[TBL] [Abstract][Full Text] [Related]
8. The Role of (18) F-FDG PET/CT in Assessing Therapy Response in Cervix Cancer after Concurrent Chemoradiation Therapy.
Choi J; Kim HJ; Jeong YH; Lee JH; Cho A; Yun M; Lee JD; Kim YB; Kim YT; Kang WJ
Nucl Med Mol Imaging; 2014 Jun; 48(2):130-6. PubMed ID: 24900153
[TBL] [Abstract][Full Text] [Related]
9. Positron-emission tomography for locally advanced cervical cancer: a survey assessing Canadian practice patterns and access.
Banerjee R; Dundas G; Doll C
Curr Oncol; 2013 Dec; 20(6):333-7. PubMed ID: 24311949
[TBL] [Abstract][Full Text] [Related]
10. The role of imaging in the management of non-metastatic cervical cancer.
Kaidar-Person O; Bortnyak-Abdah R; Amit A; Berniger A; Ben-Yosef R; Kuten A
Med Oncol; 2012 Dec; 29(5):3389-93. PubMed ID: 22531902
[TBL] [Abstract][Full Text] [Related]
11. The role of FDG-PET/CT in gynaecological cancers.
Rockall AG; Cross S; Flanagan S; Moore E; Avril N
Cancer Imaging; 2012 Mar; 12(1):49-65. PubMed ID: 22391444
[TBL] [Abstract][Full Text] [Related]
12. The promise and pitfalls of positron emission tomography and single-photon emission computed tomography molecular imaging-guided radiation therapy.
Wahl RL; Herman JM; Ford E
Semin Radiat Oncol; 2011 Apr; 21(2):88-100. PubMed ID: 21356477
[TBL] [Abstract][Full Text] [Related]
13. Chemoradiotherapy for cervical cancer in 2010.
Klopp AH; Eifel PJ
Curr Oncol Rep; 2011 Feb; 13(1):77-85. PubMed ID: 21042887
[TBL] [Abstract][Full Text] [Related]
14. Role and cost effectiveness of PET/CT in management of patients with cancer.
Saif MW; Tzannou I; Makrilia N; Syrigos K
Yale J Biol Med; 2010 Jun; 83(2):53-65. PubMed ID: 20589185
[TBL] [Abstract][Full Text] [Related]
15. PET/CT imaging to guide cervical cancer therapy.
Grigsby PW
Future Oncol; 2009 Sep; 5(7):953-8. PubMed ID: 19792965
[TBL] [Abstract][Full Text] [Related]
16. Prospective evaluation of 18F-fluorodeoxyglucose positron emission tomography-computed tomography for response evaluation in recurrent carcinoma cervix: does metabolic response predict survival?
Dhull VS; Sharma P; Sharma DN; Maharjan S; Suman Kc S; Patel C; Bal C; Kumar R
Int J Gynecol Cancer; 2014 Feb; 24(2):312-20. PubMed ID: 24407578
[TBL] [Abstract][Full Text] [Related]
17. New trends in the evaluation and treatment of cervix cancer: the role of FDG-PET.
Magné N; Chargari C; Vicenzi L; Gillion N; Messai T; Magné J; Bonardel G; Haie-Meder C
Cancer Treat Rev; 2008 Dec; 34(8):671-81. PubMed ID: 18849119
[TBL] [Abstract][Full Text] [Related]
18. Update of the role of PET/CT and PET/MRI in the management of patients with cervical cancer.
Khiewvan B; Torigian DA; Emamzadehfard S; Paydary K; Salavati A; Houshmand S; Shamchi SP; Werner TJ; Aydin A; Roy SG; Alavi A; Kumar R
Hell J Nucl Med; 2016; 19(3):254-268. PubMed ID: 27824966
[TBL] [Abstract][Full Text] [Related]
19. Clinical impact of FDG-PET imaging in post-therapy surveillance of uterine cervical cancer: from diagnosis to prognosis.
Chung HH; Kim SK; Kim TH; Lee S; Kang KW; Kim JY; Park SY
Gynecol Oncol; 2006 Oct; 103(1):165-70. PubMed ID: 16574205
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
